Kayla Pudlin Harm
Family · Fort Myers, FLNPI 1164232625
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.0% of the total across 167 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 40 manufacturers, the largest accounting for just 9.9% — the pattern of someone who eats at a lot of different presentations. Among family clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 167 payments — averaging $22.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$380
- AstraZeneca$320
- Incyte Corporation$292
- Pfizer$277
- Novartis$275
- Beone Medicines USA, Inc.$238
- plus $2K from 34 others
What the payments were for
- Food & beverage$3,62695%
- Education$1925%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 17 | $380 |
| AstraZeneca | 15 | $320 |
| Incyte Corporation | 11 | $292 |
| Pfizer | 14 | $277 |
| Novartis | 12 | $275 |
| Beone Medicines USA, Inc. | 6 | $238 |
| Merck | 9 | $217 |
| Bayer | 19 | $190 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $159 |
| Sobi, Inc | 7 | $138 |
| Daiichi Sankyo Inc. | 5 | $120 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $120 |
| Biogen | 1 | $120 |
| Gilead | 5 | $102 |
| Geron Corporation | 4 | $94 |
| E.r. Squibb & Sons, L.L.C. | 4 | $77 |
| GSK | 3 | $74 |
| Ipsen Biopharmaceuticals, Inc | 3 | $66 |
| Agios Pharmaceuticals, Inc. | 2 | $49 |
| Jazz Pharmaceuticals Inc. | 2 | $46 |
| Legend Biotech USA Inc. | 1 | $38 |
| Recordati_rare_diseases_inc. | 1 | $36 |
| Pharmacosmos Therapeutics Inc. | 2 | $33 |
| Regeneron Healthcare Solutions, Inc. | 1 | $32 |
| Sanofi | 1 | $32 |
| Array Biopharma Inc | 1 | $26 |
| Bristol Myers Squibb | 1 | $26 |
| Boehringer Ingelheim | 1 | $24 |
| Novocure Inc. | 1 | $21 |
| Adaptive Biotechnologies Corporation | 1 | $21 |
| Dendreon Pharmaceuticals LLC | 1 | $19 |
| Lilly USA, LLC | 1 | $19 |
| Taiho Oncology, Inc. | 1 | $19 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
| ADC Therapeutics America, Inc. | 1 | $18 |
| AbbVie | 1 | $17 |
| Eisai Inc. | 1 | $17 |
| Blueprint Medicines Corporation | 1 | $17 |
| Azurity Pharmaceuticals, Inc. | 1 | $16 |
| Puma Biotechnology, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,818 in reported general payments places this provider in the 90th percentile of 14,618 family providers in Florida.
Other family in Fort Myers
- Lewis HarringtonTampa$954K
- Danielle PharesFt Lauderdale$713K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
- Deena RodneyMaitland$323K
- Yamila MelendezMiami$212K
- Holly BoydLand O Lakes$200K
- Rachael BuschLoxahatchee$189K
- Victor Tatis de la NuezMiramar$161K
- Ronda CrewsJax Bch$155K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.